182 related articles for article (PubMed ID: 38233678)
21. Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
García-Grimshaw M; Michel-Chávez A; Vera-Zertuche JM; Galnares-Olalde JA; Hernández-Vanegas LE; Figueroa-Cucurachi M; Paredes-Ceballos O; Reyes-Terán G; Carbajal-Sandoval G; Ceballos-Liceaga SE; Arauz A; Valdés-Ferrer SI
Clin Immunol; 2021 Sep; 230():108818. PubMed ID: 34358692
[TBL] [Abstract][Full Text] [Related]
22. Guillain-Barre syndrome following COVID-19 vaccines: A review of literature.
Yu M; Nie S; Qiao Y; Ma Y
Front Immunol; 2023; 14():1078197. PubMed ID: 36875094
[TBL] [Abstract][Full Text] [Related]
23. Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review.
Abolmaali M; Rezania F; Behnagh AK; Hamidabad NM; Gorji A; Mirzaasgari Z
Immunol Res; 2022 Dec; 70(6):752-764. PubMed ID: 36098903
[TBL] [Abstract][Full Text] [Related]
24. Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021.
Woo EJ; Mba-Jonas A; Dimova RB; Alimchandani M; Zinderman CE; Nair N
JAMA; 2021 Oct; 326(16):1606-1613. PubMed ID: 34617967
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.
Faksova K; Walsh D; Jiang Y; Griffin J; Phillips A; Gentile A; Kwong JC; Macartney K; Naus M; Grange Z; Escolano S; Sepulveda G; Shetty A; Pillsbury A; Sullivan C; Naveed Z; Janjua NZ; Giglio N; Perälä J; Nasreen S; Gidding H; Hovi P; Vo T; Cui F; Deng L; Cullen L; Artama M; Lu H; Clothier HJ; Batty K; Paynter J; Petousis-Harris H; Buttery J; Black S; Hviid A
Vaccine; 2024 Apr; 42(9):2200-2211. PubMed ID: 38350768
[TBL] [Abstract][Full Text] [Related]
26. Post COVID-19 vaccination Guillain-Barre syndrome: three cases.
Tabatabaee S; Rezania F; Alwedaie SMJ; Malekdar E; Badi Z; Tabatabaei SM; Mirzaasgari Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2045153. PubMed ID: 35240922
[TBL] [Abstract][Full Text] [Related]
27. Population-Based Incidence of Guillain-Barré Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis.
Wang F; Wang D; Wang Y; Li C; Zheng Y; Guo Z; Liu P; Zhang Y; Wang W; Wang Y; Hou H
Front Immunol; 2022; 13():782198. PubMed ID: 35185881
[TBL] [Abstract][Full Text] [Related]
28. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.
Min YG; Ju W; Ha YE; Ban JJ; Lee SA; Sung JJ; Shin JY
J Neuroimmunol; 2021 Oct; 359():577691. PubMed ID: 34416410
[TBL] [Abstract][Full Text] [Related]
29. Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.
Goud R; Lufkin B; Duffy J; Whitaker B; Wong HL; Liao J; Lo AC; Parulekar S; Agger P; Anderson SA; Wernecke M; MaCurdy TE; Weintraub E; Kelman JA; Forshee RA
JAMA Intern Med; 2021 Dec; 181(12):1623-1630. PubMed ID: 34724025
[TBL] [Abstract][Full Text] [Related]
30. Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report.
Hwang BW; Bong JB
Medicine (Baltimore); 2022 Dec; 101(48):e32140. PubMed ID: 36482517
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barré Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
Jeong HS; Chun BC
PLoS One; 2024; 19(2):e0297902. PubMed ID: 38381729
[TBL] [Abstract][Full Text] [Related]
32. Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
Lahoz Fernandez PE; Miranda Pereira J; Fonseca Risso I; Baleeiro Rodrigues Silva P; Freitas Barboza IC; Vieira Silveira CG; Diogo Silva G; Marzorati Kuntz Puglia P; Genaro Mutarelli E
Acta Neurol Scand; 2022 Apr; 145(4):393-398. PubMed ID: 34967005
[TBL] [Abstract][Full Text] [Related]
33. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
[TBL] [Abstract][Full Text] [Related]
34. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
[TBL] [Abstract][Full Text] [Related]
35. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
Oo WM; Giri P; de Souza A
J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
[TBL] [Abstract][Full Text] [Related]
36. Sensory Ataxic Guillain-Barré Syndrome with Dysgeusia after mRNA COVID-19 Vaccination.
Ogata S; Ishii Y; Asano K; Kobayashi E; Kubota S; Takahashi K; Miyaji Y; Higashiyama Y; Joki H; Doi H; Koga M; Takeuchi H; Tanaka F
Intern Med; 2022 Jun; 61(11):1757-1760. PubMed ID: 35342134
[TBL] [Abstract][Full Text] [Related]
37. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.
Vellozzi C; Iqbal S; Broder K
Clin Infect Dis; 2014 Apr; 58(8):1149-55. PubMed ID: 24415636
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series.
Germano F; Bellucci M; Grisanti S; Beronio A; Grazzini M; Coco E; Tassinari T; Della Cava F; De Michelis C; Baldi O; Sivori G; Murialdo A; Cabona C; Durando P; Uccelli A; Schenone A; Franciotta D; Benedetti L
J Neurol Sci; 2022 Sep; 440():120330. PubMed ID: 35802961
[TBL] [Abstract][Full Text] [Related]
39. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
Hilts A; Schreiber A; Singh A
Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
[TBL] [Abstract][Full Text] [Related]
40. Guillain-Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the 'Italian factor'.
Censi S; Bisaccia G; Gallina S; Tomassini V; Uncini A
Eur J Neurol; 2024 Feb; 31(2):e16094. PubMed ID: 37823707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
